MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Wearable Device for Real-Time Prevention of Freezing-of-Gait in Parkinson’s Disease

    A. Alakhras, S. Pardoel, E. Jafari, J. Kofman, E. Lemaire, J. Nantel (Ottawa, Canada)

    Objective: In our previous work, we developed machine learning models to predict and detect freezing-of-gait (FOG) [1]. In this study, we aimed to use those…
  • 2024 International Congress

    How many days are required to reliably estimate diverse digital mobility outcomes from various gait domains with a lower back sensor in people with Parkinson’s disease?

    E. Gazit, J. Garcia-Aymerich, J. Buekers, S. Del Din, A. Mueller, W. Maetzler, A. Yarnall, C. Schlenstedt, A. Nieuwboer, A. Mirelman, H. Gassner, D. Singleton, B. Vereijken, L. Rochester, JM. Hausdorff (Tel aviv, Israel)

    Objective: To determine the  number of days needed to obtain reliable, diverse digital mobility outcomes (DMOs) from daily activity recordings obtained using a lower back,…
  • 2024 International Congress

    Examining and contextualizing free-living heart rate using multiple wearable sensors: a potential approach for assessing autonomic dysfunction in Parkinson’s disease?

    FE. Godkin, K. van Ooteghem, K. Ehgoetz Martens, K. Weber, B. Cornish, K. Beyer, D. Olszewska, C. Fearon, A. Lang, R. Swartz, M. Masellis, B. Tan, J. Tung, A. Roberts, W. Mcilroy (Waterloo, Canada)

    Objective: To examine context-specific fluctuations in free-living heart rate (HR) across a week-long multi-sensor wear period in people with Parkinson’s disease (PD). Background: Non-motor symptoms,…
  • 2024 International Congress

    Distinguishing Parkinson’s disease from atypical Parkinsonian syndrome using multistage deep learning based on dopamine transporter imaging

    JS. Park, JY. Gwak (Busan, Republic of Korea)

    Objective: We made the diagnostic model using a deep learning algorithm based on dopamine transporterWe made the diagnostic model using a deep learning algorithm based…
  • 2024 International Congress

    4-Aminopyridine improves downbeat nystagmus in SCA27b: A case report

    S. Coulette, M. Philibert, JM. Trocello, B. Gaymard, C. Desjardins (Paris, France)

    Objective: To assess objective clinical improvement in video-oculography in a patient with SCA27b on 4-aminopyridine (4-AP) treatment. Background: Spinocerebellar ataxia 27b (SCA27b; MIM 620174) is…
  • 2024 International Congress

    NGS diagnosis rate in a combined cerebellar ataxia and spastic paraplegia series from southern Spain

    A. Adarmes Gómez, S. Jesús Maestre, D. Macias Garcia, F. Carrillo Garcia, L. Muñoz Delgado, P. Gómez Garre, P. Mir (Sevilla, Spain)

    Objective: To evaluate the diagnosis rate of Next Generation Sequencing (NGS) in a combined series of patients with progressive cerebellar ataxia (CA) and progressive spastic…
  • 2024 International Congress

    Expanding the Phenotype of a Novel Mutation in ELOVL4 and the Differential Diagnosis of the Hot Cross Bun Sign

    G. Olmedo Saura, C. Pont Sunyer, I. Navalpotro Gomez, S. Bernal Noguera, B. Rodriguez Santiago, D. Guisado-Alonso, J. Pagonabarraga, C. García Sánchez, J. Kulisevsky, J. Perez Perez (Barcelona, Spain)

    Objective: To describe the clinical and radiological characteristics of three independent families affected by SCA 34 due to a recently identified mutation in ELOVL4. Background:…
  • 2024 International Congress

    Progressive Apraxia of Speech as a Presenting Symptom of Spinocerebellar Ataxia Type 2

    A. Blazek, G. Meade, L. Jackson, R. Gavrilova, J. Stierwalt, J. Martinez-Thompson, J. Duffy, H. Clark, M. Machulda, J. Whitwell, K. Josephs, R. Utianski, H. Botha (Rochester, USA)

    Objective: To describe a spinocerebellar ataxia (SCA) presenting with progressive apraxia of speech (AOS), a previously undescribed SCA phenotype. Background: Spinocerebellar ataxia type 2 (SCA2)…
  • 2024 International Congress

    Spectrum of Non-HD Hereditary Chorea- Case Series from An Indian Movement Disorder Centre

    D. Radhakrishnan, R. Rajan, A. Das, D. Garg, M. Faruq, A. Sonakar, A. Saini, A. Aliyar, J. Parihar, F. Mustafa, E. Arunmozhimaran, S. S, A. Agarwal, A. Pandit, K. Kanojia, Y. Puri, M. Tripathi, A. Srivastava (New Delhi, India)

    Objective: To identify and characterize the hereditary chorea other than Huntington’s disease (HD) in an Indian movement disorder clinic. Background: Approximately 1-3% of HD phenotypes…
  • 2024 International Congress

    A Phase IIb Double-Blind Placebo-Controlled Randomized Cross-Over Clinical Trial of Sodium Oxybate in Isolated Focal Laryngeal Dystonia

    L. O'Flynn, A. Hamzehei Sichani, S. Frucht, A. Rumbach, N. Sharma, P. Song, A. Worthley, K. Simonyan (Boston, USA)

    Objective: A phase IIb double-blind, placebo-controlled, cross-over, randomized clinical trial of a single dose of sodium oxybate investigated the efficacy and safety of the drug…
  • « Previous Page
  • 1
  • …
  • 100
  • 101
  • 102
  • 103
  • 104
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley